Presentation is loading. Please wait.

Presentation is loading. Please wait.

TZD enhances cisplatin sensitivity through suppression of endotrophin‐mediated EMT, fibrosis and angiogenesis.A,B.Schematic diagram for allografts (A),

Similar presentations


Presentation on theme: "TZD enhances cisplatin sensitivity through suppression of endotrophin‐mediated EMT, fibrosis and angiogenesis.A,B.Schematic diagram for allografts (A),"— Presentation transcript:

1 TZD enhances cisplatin sensitivity through suppression of endotrophin‐mediated EMT, fibrosis and angiogenesis.A,B.Schematic diagram for allografts (A), indicating cancer cells were isolated from tumours in PyMT (Ctrl) and PyMT/endotrophin (ETP) mice and implanted into wild‐type hosts (0.5 × 106 cells/mouse). TZD enhances cisplatin sensitivity through suppression of endotrophin‐mediated EMT, fibrosis and angiogenesis.A,B.Schematic diagram for allografts (A), indicating cancer cells were isolated from tumours in PyMT (Ctrl) and PyMT/endotrophin (ETP) mice and implanted into wild‐type hosts (0.5 × 106 cells/mouse). Host mice were given TZD (20 mg/kg) or ND diet at 10 days before implantation for tumour progression. Cisplatin (1 mg/kg, ip., every 5 days) was administered at 3‐weeks post‐implantation. Quantification of tumour volume (B), showing TZD suppressed tumour growth in endotrophin+‐tumours. Data represent mean ± SD (n = 8–9/group). *p = 0.05, **p = 0.01 and ***p = 0.001 Ctrl/ND versus ETP/ND; ##p = 0.01 and ###p = 0.001 ETP/ND versus ETP/TZD by unpaired Student's t‐test.C–F.Histological analysis of tumours in allografts after cisplatin treatment. H&E staining and necrotic area quantification (C), showing significantly increased chemo‐sensitivity in endotrophin+ tumours upon combination of TZD with cisplatin. Necrotic area (*). ***p <  and ##p =  Vimentin staining quantification (D), showing decreased EMT in both Ctrl‐ and endotrophin+‐tumours by TZD. ***p <  and ###p <  Quantification of perfused lectin staining (E), showing the increased functional blood vessels in endotrophin+‐tumours was decreased by TZD. *p = 0.015, **p = 0.001 and ##p =  Masson's Trichrome C staining quantification (F), showing increased fibrosis in endotrophin+‐tumours was decreased by TZD. ***p <  and ##p =  Scales: 200 µm (A), 100 µm (D–E) and 50 µm (F). Statistics (*Ctrl/ND/CIS vs. Ctrl/TZD/CIS or ETP/ND/CIS; #ETP/ND/CIS vs. ETP/TZD/CIS) were analysed by unpaired Student's t‐test. Jiyoung Park et al. EMBO Mol Med. 2013;5: © as stated in the article, figure or figure legend


Download ppt "TZD enhances cisplatin sensitivity through suppression of endotrophin‐mediated EMT, fibrosis and angiogenesis.A,B.Schematic diagram for allografts (A),"

Similar presentations


Ads by Google